NFKB1 and osteoarthritis: Likewise upregulation of ANK2, in both the groups was predicted to inhibit MYBBP1, which was leading to development of osteoarthritis by NF-κB activation through activation of IL-1β similar to activation of TLR2 by upregulated fibronectin.